| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 3,406.67× | 3,406.67× | 1,505.62× | 10.63× | 33.18× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 276.92× | 276.92× | 260.29× | 248.99× | 308.23× | ||
| 6,46,293.33× | 6,46,293.33× | 2,64,921.56× | 1,599.15× | 4,793.67× | ||
| −6,42,609.74× | −6,42,609.74× | −2,63,155.65× | −1,339.53× | −4,452.26× | ||
| −0.04× | −0.04× | −0.05× | −0.06× | −0.07× | ||
| 0.05× | 0.05× | 0.06× | 0.07× | 0.06× | ||
| 0.01× | 0.01× | 1.34× | 2.28× | −1.90× | ||
| 0.01× | 0.01× | 0.54× | 0.64× | −1.00× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Inventory Days (DIO) | 33.18 | 10.63 | 1,505.62 | 3,406.67 | 3,406.67 | |
| Receivable Days (DSO) | 308.23 | 248.99 | 260.29 | 276.92 | 276.92 | |
| Payable Days (DPO) | 4,793.67 | 1,599.15 | 2,64,921.56 | 6,46,293.33 | 6,46,293.33 | |
| Cash Conversion Cycle (days) | -4,452.26 | -1,339.53 | -2,63,155.65 | -6,42,609.74 | -6,42,609.74 | |
| Working Capital Turnover | -0.07 | -0.06 | -0.05 | -0.04 | -0.04 | |
| Asset Turnover | 0.06 | 0.07 | 0.06 | 0.05 | 0.05 | |
| Cash Conversion (CFO/Net Income) | -1.90 | 2.28 | 1.34 | 0.01 | 0.01 | |
| CFO/EBITDA | -1.00 | 0.64 | 0.54 | 0.01 | 0.01 |